logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
A

Ashok Gupta

Sharda University

49H指数
498论文数
3.9W被引数
收录论文 48
发表时间
logo
Assessment of Quality of Life in Acne Vulgaris Patients in Terms of Clinical Severity and Psychological Burden: A Multi Centre Study in Anand District痤疮 vulgaris 患者生活质量评估：基于临床严重程度与心理负担的多中心研究（阿南德地区）
errBANGLADESH JOURNAL OF MEDICAL SCIENCE
IF1.1
err2025-10-01
err0
errOAAI
errJha, Ambika Nand; Yashkumar, Parmar; Rajput, Dharmendra Singh; Harkhani, Chandani; Meman, Adil; Gaikwad, Varsha Ratan; Gupta, Ashok Kumar
err分享
err收藏
Novel 2D/3D Z-scheme heterojunction with Bi12O15Cl6 nanoplates anchored on MIL-53 (Fe) derived Fe2O3@C micro-rods for enhanced visible-light-mediated photocatalytic degradation of fluoroquinolones in wastewater
errSEPARATION AND PURIFICATION TECHNOLOGY
IF9
err2025-02-27
err0
PREAI
errSingh, Adarsh; Bhatnagar, Amit; Gupta, Ashok Kumar
err分享
err收藏
Crystalline porous frameworks: Advances in synthesis, mechanisms, modifications, and remediation of organic pollutants
errSEPARATION AND PURIFICATION TECHNOLOGY
IF9
err2025-01-01
err10
PREAI
errSingh, Adarsh; Soorya, K. K.; Bhatnagar, Amit; Gupta, Ashok Kumar
err分享
err收藏
Ultrasound-assisted synthesis of a novel type-II Bi12O15Cl6/CTF-1 heterojunction for visible-light-driven photocatalytic degradation of levofloxacin: Reaction kinetics, degradation pathways, and toxicity assessment
errJOURNAL OF ENVIRONMENTAL CHEMICAL ENGINEERING
IF7.2
err2024-12-01
err1
PREAI
errSingh, Adarsh; Bhatnagar, Amit; Gupta, Ashok Kumar
err分享
err收藏
Clinical Validation of Mathematically Derived Early Tumor Dynamics for Solid Tumors in Response to Durvalumab
errJCO CLINICAL CANCER INFORMATICS
IF2.8
err2024-07-01
err0
PREAI
errLi, Qin; Cristini, Vittorio; Gupta, Ashok; Achour, Ikbel; Barrett, J. Carl; Koay, Eugene J.
err分享
err收藏
Functional status of tumor-associated macrophages impacts clinical outcome of durvalumab in patients with advanced NSCLC as revealed by proteomics mass spectrometry
errCANCER RESEARCH
IF16.6
err2023-04-04
err0
PREAI
errHansen, Anna Margaret; Wang, Vivian Ying; Chambers, Andrew; Chain, David; Canales, Jaime Rodriguez; Blando, Jorge; Sweet, Steve; Cooper, Zachary A.; Gupta, Ashok; Barrett, Carl; Kim, Yeoun Jin; Achour, Ikbel
err分享
err收藏
NOVEL DIGITAL IMAGE APPROACH OF MULTIPLEX IMMUNOFLUORESCENCE BASED PD-L1 EXPRESSION ENABLES THE STRATIFICATION OF ADVANCED NSCLC PATIENTS TREATED WITH DURVALUMAB
errJOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
err2022-12-08
err0
errOAAI
errBrieu, Nicolas; Segerer, Felix; Hessel, Harald; Gupta, Ashok; Achour, Ikbel; Schmidt, Guenter
err分享
err收藏
IMMUNOGENICITY OF DURVALUMAB: ANALYSIS OF POOLED PAN-TUMOR DATA
errJOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
err2022-12-08
err0
errOAAI
errEl-Khoueiry, Anthony; Zhou, Diansong; Ozguroglu, Mustafa; Johnson, Melissa; Abou-Alfa, Ghassan; Makowsky, Mallory; Krug, Lee; Gupta, Ashok; Chen, Cecil
err分享
err收藏
DELTA-RADIOMICS PREDICTS RESPONSE AND OVERALL SURVIVAL IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH DURVALUMAB
errJOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
err2022-11-07
err0
errOAAI
errKhorrami, Mohammadhadi; Viswanathan, Vidya Sankar; Gupta, Amit; Li, Qin; Gupta, Ashok; Achour, Ikbel; Fitzgerald, Brian; Velcheti, Vamsidhar; Madabhushi, Anant
err分享
err收藏
Bioavailability of acalabrutinib suspension delivered via nasogastric tube in the presence or absence of a proton pump inhibitor in healthy subjects
errBRITISH JOURNAL OF CLINICAL PHARMACOLOGY
IF3
err2022-05-25
err3
errOAAI
errSharma, Shringi; Pepin, Xavier; Cheung, Jean; Zheng, Lianqing; Wei, Hua; Townsley, Danielle; Han, David; Majewski, Michal; Ware, Joseph A.; Mann, James; Munugalavadla, Veerendra; Sheridan, Louise; Patel, Priti; Gupta, Ashok; Tomkinson, Helen
err分享
err收藏
Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional STK11 Mutations in Patients with Non-Small Cell Lung Cancer and Is Reversed by STAT3 Knockdown
errCANCER DISCOVERY
IF33.3
err2021-07-06
err51
errOAAI
errPore, Nabendu; Wu, Song; Standifer, Nathan; Jure-Kunkel, Maria; de los Reyes, Melissa; Shrestha, Yashaswi; Halpin, Rebecca; Rothstein, Raymond; Mulgrew, Kathy; Blackmore, Stephen; Martin, Philip; Meekin, John, III; Griffin, Matthew; Bisha, Ina; Proia, Theresa A.; Miragaia, Ricardo J.; Herbst, Ronald; Gupta, Ashok; Abdullah, Shaad E.; Raja, Rajiv; Frigault, Melanie M.; Barrett, J. Carl; Dennis, Phillip A.; Ascierto, Maria Libera; Oberst, Michael D.
err分享
err收藏
Curative-Intent Treatment with Durvalumab in Early-Stage Cancers
errADVANCES IN THERAPY
IF4
err2021-04-21
err14
errOAAI
errMelillo, Giovanni; Chand, Vikram; Yovine, Alejandro; Gupta, Ashok; Massacesi, Cristian
err分享
err收藏
TUMOUR MUTATION BURDEN (TMB) AND EFFICACY OUTCOMES IN THE PHASE III DANUBE STUDY OF ADVANCED UROTHELIAL CARCINOMA (UC)
errJOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
err2020-12-10
err3
PREAI
errWildsmith, Sophie; Walker, Jill; L'Hernault, Anne; Li, Weimin; Bye, Hannah; He, Philip; Xiao, Feng; Zhang, Qu; Stewart, Ross; de los Reyes, Melissa; Raja, Rajiv; Levin, Wendy; Gupta, Ashok; Powles, Thomas; Bellmunt, Joaquim; Galsky, Matthew; Drakaki, Alexandra; van der Heijden, Michiel
err分享
err收藏
Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors
errJOURNAL OF UROLOGY
IF6.8
err2020-12-01
err65
errOAAI
errSonpavde, Guru; Manitz, Juliane; Gao, Chen; Tayama, Darren; Kaiser, Constanze; Hennessy, Daniel; Makari, Doris; Gupta, Ashok; Abdullah, Shaad Essa; Niegisch, Guenter; Rosenberg, Jonathan E.; Bajorin, Dean F.; Grivas, Petros; Apolo, Andrea B.; Dreicer, Robert; Hahn, Noah M.; Galsky, Matthew D.; Necchi, Andrea; Srinivas, Sandy; Powles, Thomas; Choueiri, Toni K.; Pond, Gregory R.
err分享
err收藏
Durvalumab activity in previously treated patients who stopped durvalumab without disease progression
errJOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
err2020-08-26
err25
errOAAI
errSheth, Siddharth; Gao, Chen; Mueller, Nancy; Angra, Natasha; Gupta, Ashok; Germa, Caroline; Martinez, Pablo; Soria, Jean-Charles
err分享
err收藏
LncRNA RP11-291B21.2 is associated with Durvalumab response in NSCLC and BLCA cancers
errCANCER RESEARCH
IF16.6
err2020-08-15
err1
PREAI
errWu, Song; Hsu, Sarah; Zhang, Qu; Greenlees, Lydia; Xiao, Mike; Gupta, Ashok
err分享
err收藏
Prognostic Significance of Liver Metastasis in Durvalumab-Treated Lung Cancer Patients
errCLINICAL LUNG CANCER
IF3.3
err2019-11-01
err40
errOAAI
errSridhar, Sriram; Paz-Ares, Luis; Liu, Hao; Shen, Kui; Morehouse, Chris; Rizvi, Naiyer; Segal, Neil H.; Jin, Xiaoping; Zheng, Yanan; Narwal, Rajesh; Gupta, Ashok; Dennis, Phillip A.; Ye, Jiabu; Mukhopadhyay, Pralay; Higgs, Brandon W.; Ranade, Koustubh
err分享
err收藏
Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108
errCANCER
IF5.1
err2019-10-03
err12
errOAAI
errO'Donnell, Peter H.; Arkenau, Hendrick Tobias; Sridhar, Srikala S.; Ong, Michael; Drakaki, Alexandra; Spira, Alexander, I; Zhang, Jingsong; Gordon, Michael S.; Degboe, Arnold N.; Gupta, Ashok K.; Mukhopadhyay, Pralay; Huang, Wenmei; Abdullah, Shaad E.; Angra, Natasha; Roskos, Lorin K.; Guo, Xiang; Friedlander, Terence
err分享
err收藏
Assessment of quality of life using WHOQOL-BREF in patients with visceral leishmaniasis使用whoqol-bref评估内脏利什曼病患者的生活质量
errHEALTH AND QUALITY OF LIFE OUTCOMES
IF3.4
err2019-03-28
err12
errOAAI
errVeeri, Rajendra Babu; Gupta, Ashok Kumar; Pal, Biplab; Siddiqui, Niyamat Ali; Priya, Devi; Das, Pradeep; Pandey, Krishna
err分享
err收藏
Early Reduction in ctDNA Predicts Survival in Patients with Lung and Bladder Cancer Treated with Durvalumab
errCLINICAL CANCER RESEARCH
IF10.2
err2018-12-13
err172
errOAAI
errRaja, Rajiv; Kuziora, Michael; Brohawn, Philip Z.; Higgs, Brandon W.; Gupta, Ashok; Dennis, Phillip A.; Ranade, Koustubh
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
J
Jedd D. Wolchok
H 指数: 173 · 论文数: 1.4K
D
Drew M. Pardoll
H 指数: 164 · 论文数: 892
F
F. Stephen Hodi
H 指数: 156 · 论文数: 1.5K
T
Toni K. Choueiri
H 指数: 149 · 论文数: 2.4K
C
Charles G. Drake
H 指数: 133 · 论文数: 1.2K
查看更多